Early Conversion of Dasatinib in CML-CP Patients
NCT04136015
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Validity and Safety
Interventions
DRUG:
Dasatinib 100 MG
Sponsor
Nanfang Hospital, Southern Medical University